Cargando…
Deep intronic deletion in intron 3 of PLP1 is associated with a severe phenotype of Pelizaeus-Merzbacher disease
Recently, altered PLP1 splicing was confirmed as a genetic cause of hypomyelination of early myelinating structures (HEMS). A novel deep intronic deletion in intron 3 of PLP1 (NM_000533.5: c.453+59_+259del) was identified, and an in vitro minigene assay detected abnormal splicing patterns. However,...
Autores principales: | Yamamoto-Shimojima, Keiko, Akagawa, Hiroyuki, Yanagi, Kumiko, Kaname, Tadashi, Okamoto, Nobuhiko, Yamamoto, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016919/ https://www.ncbi.nlm.nih.gov/pubmed/33795668 http://dx.doi.org/10.1038/s41439-021-00144-y |
Ejemplares similares
-
A novel PLP1 mutation F240L identified in a patient with connatal type Pelizaeus-Merzbacher disease
por: Lu, Yongping, et al.
Publicado: (2017) -
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease
por: Epplen, Dirk B, et al.
Publicado: (2015) -
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
por: Kouga, Takeshi, et al.
Publicado: (2019) -
Pelizaeus-Merzbacher disease in siblings
por: Mittal, Amit, et al.
Publicado: (2010) -
The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series
por: Trepanier, Angela M., et al.
Publicado: (2023)